Symbollon Pharmaceuticals Inc (fka SYMBA)

[Something-Special]

Added to The Stock Wizards Hot stocks list today

MEDFIELD, MA, Mar 04, 2010 Symbollon Pharmaceuticals, Inc. (OTCBB: SYMBA) (www.symbollon.com) is pleased to announce that it has initiated retail sales of iogen(TM), its patented dietary supplement for improving women’s breast health, through its web site, www.buyiogen.com. Iogen is the first dietary supplement formulated to promote breast health for women. As part of the initial launch, iogen will be available for a limited-time introductory price of $19.95 (a 70% discount off the retail price) for a 2-month supply. The offer is backed by a 60-day money back guarantee.

Technical outlook: SYMBA broke a critical resistance level of .20 in this morning’s trading. A weekly close above this level would be very bullish for the stock. The technicals are very strong on the charts. SYMBA is up 65% on 671 million shares in early trading.
About Symbollon Pharmaceuticals, Inc. (OTCBB: Symbollon Pharmaceuticals, Inc. (OTCBB: SYMBA) ) Symbollon is a specialty biotechnology company focused on the development and commercialization of proprietary products based on its molecular iodine technology for women’s healthcare and antimicrobials uses. For more information about Symbollon, please visit the company’s website at http://www.symbollon.com.